Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption
Top Cited Papers
Open Access
- 1 March 2023
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 20 (1) , 1-19
Abstract
Objectives: Neuroinflammation has been suggested that affects the processing of depression. There is renewed interest in berberine owing to its anti-inflammatory effects. Herein, we investigated whether berberine attenuate depressive-like behaviors via inhibiting NLRP3 inflammasome activation in mice model of depression. Methods: Adult male C57BL/6N mice were administrated corticosterone (CORT, 20 mg/kg/day) for 35 days. Two doses (100 mg/kg/day and 200 mg/kg/day) of berberine were orally administrated from day 7 until day 35. Behavioral tests were performed to measure the depression-like behaviors alterations. Differentially expressed gene analysis was performed for RNA-sequencing data in the prefrontal cortex. NLRP3 inflammasome was measured by quantitative reverse transcription polymerase chain reaction, western blotting, and immunofluorescence labeling. The neuroplasticity and synaptic function were measured by immunofluorescence labeling, Golgi–Cox staining, transmission electron microscope, and whole-cell patch-clamp recordings. Results: The results of behavioral tests demonstrated that berberine attenuated the depression-like behaviors induced by CORT. RNA-sequencing identified that NLRP3 was markedly upregulated after long-term CORT exposure. Berberine reversed the concentrations of peripheral and brain cytokines, NLRP3 inflammasome elicited by CORT in the prefrontal cortex and hippocampus were decreased by berberine. In addition, the lower frequency of neuronal excitation as well as the dendritic spine reduction were reversed by berberine treatment. Together, berberine increases hippocampal adult neurogenesis and synaptic plasticity induced by CORT. Conclusion: The anti-depressants effects of berberine were accompanied by reduced the neuroinflammatory response via inhibiting the activation of NLRP3 inflammasome and rescued the neuronal deterioration via suppression of impairments in synaptic plasticity and neurogenesis.Keywords
Funding Information
- National Natural Science Foundation of China (31900730)
- Shanghai Science and Technology Committee (20XD1423100)
This publication has 45 references indexed in Scilit:
- Autocrine Action of BDNF on Dendrite Development of Adult-Born Hippocampal NeuronsThe Journal of Neuroscience, 2015
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder TherapeuticsAnnual Review of Medicine, 2015
- NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorderBrain, Behavior, and Immunity, 2014
- NLRP3 Inflammasome: A New Target in Major Depressive DisorderCNS Neuroscience & Therapeutics, 2014
- Synaptic Dysfunction in Depression: Potential Therapeutic TargetsScience, 2012
- CX3CR1 Deficiency Leads to Impairment of Hippocampal Cognitive Function and Synaptic PlasticityThe Journal of Neuroscience, 2011
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major DepressionBiological Psychiatry, 2009
- Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disordersTrends in Pharmacological Sciences, 2008
- Major Depressive DisorderNew England Journal of Medicine, 2008
- The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoidsNature Neuroscience, 2005